Product Name :
Pentiapine
Description:
Pentiapine (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites.
CAS:
81382-51-6
Molecular Weight:
299.39
Formula:
C15H17N5S
Chemical Name:
5-(4-methylpiperazin-1-yl)benzo[f]imidazo[2, 1-b][1, 3, 5]thiadiazepine
Smiles :
CN1CCN(CC1)C1=NC2=CC=CC=C2SC2=NC=CN21
InChiKey:
FACMWMBWGSPRKO-UHFFFAOYSA-N
InChi :
InChI=1S/C15H17N5S/c1-18-8-10-19(11-9-18)14-17-12-4-2-3-5-13(12)21-15-16-6-7-20(14)15/h2-7H,8-11H2,1H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.Piroxicam Immunology/Inflammation
Shelf Life:
≥12 months if stored properly.Pralsetinib medchemexpress
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Pentiapine (CGS 10746) is a dopamine release inhibitor without binding to synaptic dopamine receptor sites.PMID:33241972 |Product information|CAS Number: 81382-51-6|Molecular Weight: 299.39|Formula: C15H17N5S|Chemical Name: 5-(4-methylpiperazin-1-yl)benzo[f]imidazo[2, 1-b][1, 3, 5]thiadiazepine|Smiles: CN1CCN(CC1)C1=NC2=CC=CC=C2SC2=NC=CN21|InChiKey: FACMWMBWGSPRKO-UHFFFAOYSA-N|InChi: InChI=1S/C15H17N5S/c1-18-8-10-19(11-9-18)14-17-12-4-2-3-5-13(12)21-15-16-6-7-20(14)15/h2-7H,8-11H2,1H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 100 mg/mL (334.01 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Pentiapine is a novel dopamine release inhibitor.The results show that Pentiapine dose-dependently reduces motor activity of mice. Moreover, Pentiapine dose-dependently reduces morphine-induced hyperactivity. Newman-Keuls post-hoc comparisons indicate that the group receiving morphine plus saline presents more activity than the groups receiving morphine plus 2 (PProducts are for research use only. Not for human use.|
